RESULTS OF THE WUPPSC STUDY: PROSPECTIVE MULTICENTER WITHDRAWAL OFURSODEOXYCHOLIC
ACID IN PEDIATRIC PRIMARY SCLEROSING CHOLANGITIS (PSC). Dennis Black1, Cara Mack2, Nanda Kerkar3,5, Tamir Miloh4, Shikha Sundaram2, Ravinder Anand6, Ashutosh Gupta6, Estella Alonso7, Ronen Arnon8, Pinar Bulut9, Saul Karpen10, Chuan-Hao Lin5, Philip Rosenthal11, Matthew Ryan12, Robert Squires13, Pamela Valentino14, Benjamin Shneider4. 1Pediatrics, University of Tennessee Health Science Center, Memphis, TN, USA; 2Pediatrics, University of Colorado School of Medicine, Aurora, CO, USA; 3Pediatrics, University of Rochester Medical Center, Rochester, NY, USA; 4Pediatrics, Baylor College of Medicine, Houston, TX, USA; 5Pediatrics, Keck School of Medicine of USC, Los Angeles, CA, USA; 6Emmes Corporation, Rockville, MD, USA; 7Pediatrics, Northwestern University College of Medicine, Chicago, IL, USA; 8Pediatrics, Mount Sinai Icahn School of Medicine, New York, NY, USA; 9Pediatrics, Phoenix Children's Hospital, Phoenix, AZ, USA; 10Pediatrics, Emory University School of Medicine, Atlanta, GA, USA; 11Pediatrics, University of California, San Francisco, School of Medicine, San Francisco, CA, USA; 12Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, USA; 13Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; 14Pediatrics, Yale School of Medicine, New Haven, CT, USA.